Corporate Announcement
Security Code : 533573    Company : APLLTD    
 
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDownload PDFDownload XBRL
  Exchange Received Time  22/11/2019 12:05:33         Exchange Disseminated Time   22/11/2019 12:05:43              Time Taken   00:00:10
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for its following Abbreviated New Drug Applications (ANDAs):

1. Final Approval for Deferasirox Tablets 90 mg and 360 mg.
2. Final Approval for Deferasirox Tablets for Oral Suspension, 125 mg, 250 mg, and 500 mg.
3. Tentative Approval for Deferasirox Tablets 180 mg.

Please find enclosed herewith our press release.

We request you to kindly take the same on record.
 

Disclaimer

Back To Announcements